Literature DB >> 18563325

Evaluation of the left ventricular remodeling in patients with myocardial infarction after revascularization with intravenous real-time myocardial contrast echocardiography.

Xiaojun Bi1, Youbin Deng, Weihui Shentu, Li Xiong, Yun Zhang, Fen Yu, Runqing Huang.   

Abstract

In order to evaluate the left ventricular remodeling in patients with myocardial infarction after revascularization with intravenous real-time myocardial contrast echocardiography (RT-MCE), intravenous RT-MCE was performed on 20 patients with myocardial infarction before coronary revascularization. Follow-up echocardiography was performed 3 months after coronary revascularization. Segmental wall motion was assessed using 18-segment LV model and classified as normal, hypokinesis, akinesis and dyskinesis. Myocardial perfusion was assessed by visual interpretation and divided into 3 conditions: homogeneous opacification=1; partial or reduced opacification or subendocardial contrast defect=2; contrast defect=3. Myocardial perfusion score index (MPSI) was calculated by dividing the total sum of contrast score by the total number of segments with abnormal wall motion. Twenty patients were classified into 2 groups according to the MPSI: MPSI<or=1.5 as good myocardial perfusion, MPSI>1.5 as poor myocardial perfusion. To assess the left ventricular remodeling, the following comparisons were carried out: (1) Comparisons of left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVEDV) before and 3 months after revascularization in two groups; (2) Comparisons of LVEF, LVESV and LVEDV pre-revascularization between two groups and comparisons of these 3 months post-revascularization between two groups; (3) Comparisons of the differences in LVEF, LVESV and LVEDV between 3 months post-and pre-revascularization (DeltaLVEF, DeltaLVESV and DeltaLVEDV) between two groups; (4) The linear regression analysis between DeltaLVEF, DeltaLVESV, DeltaLVEDV and MPSI. The results showed that the LVEF obtained 3 months after revascularization in patients with MPSI>1.5 was obviously lower than that in those with MPSI<or=1.5. The LVEDV obtained 3 months post-revascularization in patients with MPSI>1.5 was obviously larger than that in those with MPSI<or=1.5 (P=0.002 and 0.04). The differences in DeltaLVEF and DeltaLVEDV between patients with MPSI>1.5 and those with MPSI<or=1.5 were significant (P=0.002 and 0.001, respectively). Linear regression analysis revealed that MPSI had a negative correlation with DeltaLVEF and a positive correlation with DeltaLVESV, DeltaLVEDV (P=0.004, 0.008, and 0.016, respectively). It was concluded that RT-MCE could accurately evaluate the left ventricular remodeling in patients with myocardial infarction after revascularization.

Entities:  

Mesh:

Year:  2008        PMID: 18563325     DOI: 10.1007/s11596-008-0313-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Myocardial contrast echocardiography predicts left ventricular remodelling after acute myocardial infarction.

Authors:  Paramjit Jeetley; Jonathan Swinburn; Michael Hickman; Nick G Bellenger; Dudley J Pennell; Roxy Senior
Journal:  J Am Soc Echocardiogr       Date:  2004-10       Impact factor: 5.251

2.  Intravenous myocardial contrast echocardiography predicts regional and global left ventricular remodelling after acute myocardial infarction: comparison with low dose dobutamine stress echocardiography.

Authors:  Y Abe; T Muro; Y Sakanoue; R Komatsu; M Otsuka; T Naruko; A Itoh; M Yoshiyama; K Haze; J Yoshikawa
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

3.  Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications.

Authors:  Leonardo Bolognese; Aleksandar N Neskovic; Guido Parodi; Giampaolo Cerisano; Piergiovanni Buonamici; Giovanni M Santoro; David Antoniucci
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

4.  Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography.

Authors:  J H Myers; M C Stirling; M Choy; A J Buda; K P Gallagher
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

5.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

Authors:  J L Rouleau; J de Champlain; M Klein; D Bichet; L Moyé; M Packer; G R Dagenais; B Sussex; J M Arnold; F Sestier
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

6.  Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography.

Authors:  D A Touchstone; G A Beller; T W Nygaard; C Tedesco; S Kaul
Journal:  J Am Coll Cardiol       Date:  1989-06       Impact factor: 24.094

7.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

8.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

9.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction.

Authors:  H Ito; A Maruyama; K Iwakura; S Takiuchi; T Masuyama; M Hori; Y Higashino; K Fujii; T Minamino
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

10.  Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.

Authors:  P Gaudron; C Eilles; I Kugler; G Ertl
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.